RNA Technology Analysis
🇪🇺 EMAExpert commentary and market intelligence for pharma strategy teams
Showing 1–2 of 2 articles
Earlier
High impact AnalysisJun 2, 2026
ASCO26: Summit, Akeso claim OS victory for ivonescimab in pivotal Chinese study
8 min
Dr. Elena RossiHigh impact AnalysisJun 2, 2026
Intellia Therapeutics to Report Additional Phase 3 HAELO Data for Lonvoguran Ziclumeran (lonvo-z) in Late-Breaking Oral Presentation at EAACI 2026
9 min
Dr. Elena RossiExplore intelligence